Medtech Funding and Preparing for Due Diligence

 
It’s tough. I mean, we can’t sit here or stand here and pretend that it’s, you know, it’s roses and rainbows everywhere. It’s definitely a difficult landscape, especially for very early stage companies to do fundraising right now. They shouldn’t be discouraged by that. There is money being invested.
— Devon Campbell

Join Devon Campbell and Global Medical Device Podcast host Etienne Nichols as they explore the current medical device start-up funding climate in episode 334. They try to spark glimmers of hope by sharing tips to help you know your weaknesses, fill the gaps, and increase your odds in finding funding.

Devon and Etienne dive into topics such as the importance of understanding the risk profiles, objectives, and expectations of different funding sources, product readiness, QMS maturity, avoiding smoke and mirrors by being fully authentic and transparent, and how to build unshakeable confidence.

In a world where investor confidence becomes your MedTech start-up currency… data integrity is key, risk management becomes your best friend, and quality is more than just a thing you do… it’s the whole point.

 
 
Previous
Previous

Regulatory Considerations for Medtech Startup Growth

Next
Next

Best Practices for Early Stage Founders